Analysts forecast that the Global Implantable Cardioverter Defibrillator (ICD) will reach $7.8 billion in 2014. One of the key factors contributing to this market growth is the positive effects of remote monitoring of patients.  The ICD market has also been witnessing mergers and acquisition between vendors. However the saturation of ICD market could be a challenge to the growth of this market.

Key vendors dominating this market space include Medtronic Inc, St.Jude Medical Inc, Boston Scientific Corporation, Sorin Group, and Biotronik Inc.

The Global Implantable Cardioverter Defibrillator (ICD) 2010-2014 report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on Americas, EMEA and APAC and covers the market of Global Implantable Cardioverter Defibrillator (ICD).

Key questions answered in this report:

What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

TABLE OF CONTENTS

01. Executive Summary

02. Introduction

03. Market Landscape

04. Vendor Landscape

05. Market Growth Drivers

06. Market Challenges

07. Market Trends

08. Key Vendor Analysis
08.1 Medtronic Inc
08.2 St. Jude Medical Inc
08.3 Boston Scientific Corporation
08.4 Sorin Group
08.5 Biotronik Inc

09. Other Reports in this Series

LIST OF EXHIBITS

Exhibit 1: Overall Global Implantable Cardioverter Defibrillator Market 2010-2014 ($ billion)
Exhibit 2: Global Implantable Cardioverter Defibrillator by Geography (2010)
Exhibit 3: Market Share of Key Global Implantable Cardioverter Defibrillator - 2010